(Q39556474)

English

The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer

scientific article published on 18 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer (English)

1 reference

Europe PubMed Central

13 September 2017

1 reference

based on heuristic

inferred from title

peritoneal carcinomatosis

1 reference

based on heuristic

inferred from title

Noriomi Matsumura

2

object named as

Noriomi Matsumura

1 reference

Europe PubMed Central

13 September 2017

3

object named as

Masaki Mandai

1 reference

Europe PubMed Central

13 September 2017

14

object named as

Ikuo Konishi

1 reference

Europe PubMed Central

13 September 2017

6

object named as

Tsukasa Baba

1 reference

Europe PubMed Central

13 September 2017

Junzo Hamanishi

7

object named as

Junzo Hamanishi

1 reference

Europe PubMed Central

13 September 2017

11

object named as

Kaoru Abiko

1 reference

Europe PubMed Central

13 September 2017

Susan K. Murphy

13

object named as

Susan K Murphy

1 reference

Europe PubMed Central

13 September 2017

9

object named as

Hyun Sook Kang

1 reference

Europe PubMed Central

13 September 2017

1

object named as

Shogo Yamamura

1 reference

Europe PubMed Central

13 September 2017

4

object named as

Zhiqing Huang

1 reference

Europe PubMed Central

13 September 2017

5

object named as

Tomonori Oura

1 reference

Europe PubMed Central

13 September 2017

author name string

Ken Yamaguchi

8

1 reference

Europe PubMed Central

13 September 2017

Takako Okamoto

10

1 reference

Europe PubMed Central

13 September 2017

Seiichi Mori

12

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

18 April 2011

1 reference

Europe PubMed Central

13 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

13 September 2017

130

1 reference

Europe PubMed Central

13 September 2017

1

1 reference

Europe PubMed Central

13 September 2017

20-28

1 reference

Europe PubMed Central

13 September 2017

Mechanisms of transcoelomic metastasis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

TGF-beta signaling in tumor suppression and cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Roles of TGFbeta in metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Patterns of cell signaling pathway activation that characterize mammary development.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Yin yang 1 modulates taxane response in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Anchorage-independent cell growth signature identifies tumors with metastatic potential

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Two major Smad pathways in TGF-beta superfamily signalling.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

TGFbeta in Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25961

21 January 2018

Identifiers

10.1002/IJC.25961

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39556474&oldid=1858324315"